Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-D]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(MTDIA)

Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-D]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(MTDIA)

US Patent 10227351 · Granted Mar 12, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for treatment of bacterial infections2025
Inhibitors of DNMT1 as anticancer therapeutic agents2022
Treatment of helicobacter pylori infections2021
Treatment of helicobacter pylori infections2021
Heparan sulfate glycomimetic compounds and their pharmaceutical and cosmeceutica2021
Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-d]pyrimidin-7-2018
Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-d]pyrimidin-7-2018
Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-d]pyrimidin-7-2018
3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucl2018
3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucl2018
Saccharide dendritic cluster compounds as inhibitors of BACE-12018
Dendritic core compounds2017